Skip to content

To evaluate the effect of Qizhiweitong granules on biomarkers in patients with chronic non-atrophic gastritis based on metabolomics

To evaluate the effect of Qizhiweitong granules on biomarkers in patients with chronic non-atrophic gastritis based on metabolomics

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2100004932
Enrollment
Unknown
Registered
2021-06-10
Start date
2021-06-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic non-atrophic gastritis

Interventions

Sponsors

The First Hospital of Hebei Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged older than 18 years; 2. Patients were diagnosed as chronic non-atrophic gastritis (treatment group) by doctors and gastroscopy and pathological examination, otherwise they were considered as healthy subjects (control group); 3. Have not taken any drugs or health care products in the 14 days before enrollment; 4. Signing the informed consent.

Exclusion criteria

Exclusion criteria: 1. Menstrual, pregnant and lactating women; 2. Metabolism related diseases and other digestive diseases; 3. Subjects who reported other digestive diseases, such as peptic ulcer, panpancreatitis, hepatitis, and cirrhosis of the liver; 4. Severe heart, brain, liver, kidney or hematopoietic system dysfunction or other serious diseases; 5. Serious mental illness (such as schizophrenia, depression, anxiety, etc.); 6. Some factors that affect stomach function, such as diet and lifestyle; 7. Food or drug allergies; 8. Unable to return to the doctor on time, lost to follow-up or incomplete data; 9. Discontinuation of treatment due to adverse reactions.

Design outcomes

Primary

MeasureTime frame
Endogenous substances in urine;Endogenous substances in plasma;Endogenous substances in saliva;

Countries

China

Contacts

Public ContactWang Jianxin

The First Hospital of Hebei Medical University

wjx1561@126.com+86 15630135915

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026